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Abstract
Background: Since 1998, in the countries where there is mandatory fortification of grain products with folic acid,
folate deficiency has become very rare. Consequently, we decided to find out whether there is any justification for
ordering folate assays for investigation of anemias.
Methods: We reviewed serum folate (SF) and red cell folate (RF) data at two teaching hospitals in Canada. At the
Health Sciences Centre (HSC) the folate data for the year 2001 were analyzed and the medical records of those
with low SF or low RF were reviewed. At St. Boniface General Hospital(SBGH)all folate data between January 1996
and Dec 31,2004 were analyzed and the medical records of all who had low RF between January 1,1999 and
December 31,2004 were reviewed.
Results: In 2001, at HSC, 11 out of 2154(0.5%)SF were low(<7.0 nmol/L) and 4 out of 560 (0.7%) RF were low (<417
nmol/L). In no subject with low SF or RF could the anemia be attributed to folate deficiency. At SBGH during the
3-year-period of 1999-2001, 19 out of 991(1.9%) had low RF (<225 nmol/L) but in only 2 patients (0.2%) the low RF
was in folate deficiency anemia range; but neither of them had anemia.
Conclusion: In countries where there is mandatory fortification of grain products with folic acid, folate deficiency
to the degree that could cause anemia is extremely rare. Ordering folate assays for investigation of anemias, in
these countries, is waste of time and money. The result of these tests is more likely to mislead the physicians than
to provide any useful information.
Background
During the period of 1940-60, folate deficiency in a
patient was not recognized until it had advanced enough
to cause megaloblastic anemia. With the development of
folate assays, folate deficiency could be identified much
earlier. These assays provided data which showed the
high prevalence of folate deficiency in: pregnancy, pre-
mature infants, hemolytic anemias, malabsorption syn-
drome and alcoholics. Furthermore, research showed a
link between folate deficiency and pregnancy complica-
tions such as abruptio placenta, eclampsia, congenital
malformations, especially neural tube defect (NTD),
hyperhomocysteinemia, occlusive cardiovascular disor-
ders and neuropsychiatric disorders. Serum folate (SF)
and red cell folate (RF) became commonly ordered tests,
for investigation of anemias and conditions cited above.
In 1996, in order to reduce the development of NTD,
US Food and Drug Administration mandated that by
January 1, 1998 all grain products must be fortified with
0.14 mg of folic acid per 100 g of grain [1]. Health
Canada also mandated a similar folic acid fortification of
grain products with the deadline of November 1, 1998
[2]. At that time, it was estimated that such fortification
of grain products would add an average of 0.1 mg folic
acid to the daily intake of folate by adults. This manda-
tory fortification of grain products markedly reduced the
prevalence of folate deficiency and increased the mean
SF and RF of the population [3-7].
In February, 2002, one of us (AMS), after noticing that
in the year 2001, less than 1% of folate assays performed
were low, notified the physicians and the wards at St.
Boniface General Hospital (SBGH) that “Since
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folate deficiency has become extremely rare. Conse-
quently, the laboratory would no longer accept an order
for folate assay, unless the physician could justify order-
ing these tests”. Subsequently, Health Science Centre
(HSC) and all other public laboratories (laboratories
located in hospitals) in the province of Manitoba, dis-
continued providing folate assays and referred the tests
to SBGH. SBGH remained the only public laboratory for
performance of folate assays in the Province of Mani-
toba, Canada. This policy resulted in marked reduction
of folate assays performed at SBGH for all public labora-
tories in Manitoba. Consequently, we decided to find
out whether there was any need for folate assays for
investigation of anemias.
Methods
This was a retrospective study of folate data and a
review of all medical records of the patients with low SF
or RF at HSC and SBGH, the two teaching hospitals in
Manitoba. According to the policy at the time, the
approval of the Medical Director and Director of Health
Records of the two institutions was obtained prior to
review of patient’s records.
SBGH had been using the same L. Casei microbiologi-
cal assay of serum folate and red cell folate since 1966.
SF was determined using the method of Waters and
Mollin [8]. RF was determined by measuring SF and
whole blood folate and calculating the red cell folate [9].
SBGH data was used to determine the changes in SF
and RF before and after folic acid fortification. During
2001, HSC was using a competitive binding assay of
folate (IMX system, Abbott Laboratories Diagnostic
Division, Abbott Park, Il). Normal range for this assay
was established in 1997. HSC data was used to demon-
strate the prevalence of low SF and low RF post folic
acid fortification era.
KvK reviewed all the folate assays performed at HSC in
2001 and reviewed the hospital records of those who had
low SF or RF, to find out the cause of low folate and rela-
tion of the low folates to the patient’sa n e m i a .A M S ,
using the laboratory information system (LIS), reviewed
all folate assays performed at SBGH for the periods 1996-
2004 and reviewed the hospital records of only those who
had low RF, to see if there was any explanation for low
RF or any hematological abnormality to support the diag-
nosis of folate deficiency anemia (macrocytosis and/or
increased number of hypersegmented polymorphs or
megaloblastic changes in the bone marrow).
Results
Analysis of SF data at HSC
The normal SF at HSC in 2001 was >7.0 nmol/L. Of the
2154 SF assayed in 2001, 11 (0.5%) were low (SF of 3.9-
6.6 nmol/L). All 11 patients were anemic but their SF
were not as low as those seen in folate deficiency ane-
m i a( s e ec o m m e n t sb e l o w ) .O n l yo n ec a s eh a dah i g h
mean corpuscular volume (MCV). This patient had
ethanol induced pancreatitis and an SF of 4.8 nmol/L.
Two patients with celiac disease had slightly low serum
folates of 6.3 and 6.1 nmol/L. One referred-in sample
had a low SF, low serum B12 (SB12) and low serum ferri-
tin (malabsorption syndrome?). In the other seven
patients there was no evidence of folate deficiency ane-
mia and no explanation could be found to why their SFs
were low.
Analysis of RF Data at HSC
The normal range for RF at HSC was >422 nmol/L. In
2001, among 560 RFs performed, 4 patients (0.7%) had
low RF. In one case, the low RF of 417 nmol/L was due
to B12 deficiency. The second case was the same patient
with ethanol induced pancreatitis who also had low SF.
The other two had celiac disease.
Analysis of the SF Data at SBGH
The normal range for serum folate at SBGH was >6.8
nmol/L. The percentage of low SF at SBGH was much
higher than that in HSC, because SBGH was using a
microbiological assay which gives falsely low results if
the patient is on antibiotics or antimetabolites. Table 1
shows the number of SF, the percentage of those with
low SF and the mean SF in different periods between
1996 and 2004. During the 24-month-period of January
1, 1996-December 31, 1997, 2602 SF were assayed with
the mean SF of 17.1 nmol/L. Of these, 598 (22.9%) were
below normal. During the 36-month-period of January
1, 1999-December 31, 2001, 4464 SF were performed
with the mean SF of 30.1 nmol/L. Of these, 242 (5.2%)
were below normal. During the 3-year-period of January
Table 1 Serum folates (S. folate) performed at SBGH (1996-2004)
Year Number # of low S. folate % of low S. folate Mean S. Folate (nmol/L)
1996-8 2602 598 22.9% 17.1
1999-01 4464 242 5.20% 30.1
2002-04 24 0 0.0% 37.9
The difference between the mean, number and percentage of low serum folates for the periods of 1996-98 and 1999-2001 is significant (P < 0.001) but between
1999-2001 and 2002-04 is not significant.
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why a SF or RF was needed (generally because the
patient had a macrocytica n e m i aw i t hn o r m a lS B 12 or
because malabsorption syndrome was suspected) only
24 SF were assayed, with the mean SF of 37.9 nmol/L.
Significantly, none of these 24 SF were low. Ironically,
Physicians, in private office, who did not have to provide
reason for ordering folate assays, continued to order
folate assays, at increasing rate. During the 3-year-period
of 2002-2004 when public laboratories performed only
24 SF, the private laboratories charged Manitoba Health
Department for performing 28,136 serum folate assays.
Analysis of the red cell folates data at SBGH
The normal RF at SBGH was >225 nmol/L. Red cell
folates at SBGH were also determined by microbiologi-
cal assays. However, because the whole blood has to be
diluted 1:10 for RF assay, this dilution minimizes the
inhibitory effect of most of the antibiotics and antimeta-
bolites on the growth of L. Casei used for folate assay.
Because of this, and also because low red cell folate cor-
relates much better than low serum folate with folate
deficiency anemia, a more detailed analysis was per-
formed on the RF, and only the medical records of
those with low RF were reviewed. Furthermore, because
some grain companies had started fortifying their pro-
ducts with folic acid by late 1996 and most of the
others by January, 1998, we analyzed the RF data year
by year to see the effect of this folic acid fortification.
Table 2 shows the number and the percentages of those
with low RF for the periods of January 1996-December
2004. The percentage of low RF in 1996 was 18.5%; in
1997, 11.5%; in 1998, 4.5% and for the 3-year period of
1999-2001, it was 1.6%. The mean RF rose from 509
nmol/L in 1996 to 947 nmol/L in the post folic acid
fortification period. During the 3-year-period of 1999-
2001, 19 of 991 RFs (1.9%) were low. Of these, three
had normal SF, 9 patients were ethanol abusers with
alcoholic liver disease; 7 patients had celiac disease; two
patients had low RF because of a severe B12deficiency;
and one patient had AIDS with extreme malnutrition,
(low RF, SB12 and serum ferritin). Of 7 patients with
celiac disease, only one had a high MCV of 103.3 fl
with RF of 173 nmol/L. Only two patients had RF in
the folate deficient anemia range of <100 nmol/L, but
were not anemic.
During the 3-year period of 2002-2004, when physi-
cians had to justify why folate assay was needed, only 34
RF were assayed with the mean RF of 831 nmol/L. Of
these 34 patients only one patient with celiac disease,
had a slightly low RF of 206 nmol/L with a normal SF
of 7.3 nmol/L.
Limitation of this study - Because this was a retro-
spective study, we could not make sure that proper data
is available for investigation of the anemia in every
patient. Folate assays were not necessary ordered at the
same time that complete blood count (CBC) was
ordered; and not all patients had proper description of
blood smear or additional confirmatory tests such as
serum homocysteine or bone marrow examination. We
used the closest CBC result prior to ordering folate
assays.
Discussion
Fortification of grain products with folic acid was man-
dated in order to add about 0.1 mg folate to the daily
intake of an adult. Some studies have shown that the
resulting increase, in daily folate intake, is about 0.2 mg
[10,11]. Even if a patient has no other source of folate
intake, a daily intake of 0.1 mg folic acid is more than
enough to prevent folate deficiency anemia. In fact,
patients with folate deficiency megaloblastic anemia can
be treated with as little as 0.025 mg [12] or 0.050 mg
[13] of folic acid daily.
Only 11 of 2154 (0.5%) SF assayed at HSC during
2001 were subnormal. In none of these patients, was the
SF as low as is seen in patients with folate deficiency
anemia. Similarly, in none of the patients seen at SBGH
after 1998, could the anemia or macrocytosis be attribu-
ted to folate deficiency. In the National Health and
Nutrition Examination Survey (NHANES) of 1999-2000
in USA [6,7], the prevalence of low SF (<6.8 nmol/L)
was 0.5% (compared to 16% in NHANES III for the per-
iod of 1988-1994) [6]. The prevalence of low SF and low
RF reported by a large private Laboratory in Canada,
during the period of February 1, 1999 to March 31,
Table 2 Red cell folates (R. folate) performed at SBGH (1996-2004)
Year Number # of low R. folate % of low R.folate Mean R. folate (nmol/L)
1996 511 95 18.5 509
1997 474 56 11.5 588
1998 581 17 4.5 858
1999-01 991 19 1.9 947
2002-04 34 1 2.9 831
The difference between the mean, number or percentage of low red cell folates in 1996 and 1997 is significant (P < 0.01), between those of 1997 and 1998 is
also significant (P < 0.001), but the differences between those of 1998, 1999-2001 and 2002-2004 are not significant, based on Chi square calculation and t-test
(By January first 1998 almost all of grain products in Canada were fortified with folic acid).
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colleagues [14] from Cleveland Clinic found 77 of 4985
(1.6%) SFs during 2001 were lower than normal. The
MCV of these 77 patients was not different from those
with normal SF. Only 39 of 74 patients with low SFs
(0.9% of clinically suspected folate deficient patients)
were actually prescribed folic acid. They commented
that true folate deficiency is very rare; and questioned
whether there is a role for folate determinations in clini-
cal practice in the USA [14]. The prevalence of subnor-
mal SF at HSC during 2001 (0.5%) was similar to
prevalence of low SF in random population survey
1999-2000 of NHANES (0.5%) [6]. Joelson et al [15]
reviewed the red cell folate data of 3 USA county hospi-
tals with large cohort of indigent patients, during the
years 1997, 2000 and 2004. Cutoffs for RF in these hos-
pitals were 362 and 213 nmol/L. Using a RF cutoff 362
nmol/L, the combined incidence of folate deficiency
decreased from 4.8% in 1997 to 0.6% in 2004. At a cut-
off of 213 nmol/L, the incidence dropped from 0.98% to
0.09% [15]. They concluded that routine folate measure-
ments for patients with anemia and/or macrocytosis is
difficult to justify.
Problems with Folate Assays and Normal Range
There are numerous methods for folate assays, each giv-
ing different result for assay of the same sample. Gunter
et al [16] reported on interlaboratory comparison of SF
and RF performed by 20 research laboratories (8 using
L. Casei microbiological assays and 12 using competitive
binding methods). Aliquots of six normal serum and
blood were sent to each of 20 laboratories to perform
duplicate assays on each sample daily for three days.
There were a two to nine-fold differences in reported
folate concentrations between the methods. In profi-
ciency testing of the College of American Pathologists
f o rf o l a t ea s s a y s[ 1 7 ] ,w h e na l i q u o t so fo n es a m p l eo f
serum were sent to 1233 laboratories, using 12 different
competitive binding methods of folate assays, the mean
SF for the laboratories that were using the same method
of folate assay ranged from 6.95 to 18.75. At SBGH
where the same microbiological assay of folates had
been performed since 1966, the normal RF was >225
nmol/L; and in folate deficiency megaloblastic anemias,
RF was <100 nmol/L. It is for these reasons that we
have commented that, in our study, in none of the sub-
jects the anemia could be attributed to folate deficiency.
The normal range of SF and RF varies depending on
the geographical location, the season during which the
samples were obtained for determining the normal
range and the average folate intake of the population.
When SF or RF of a patient is low, it does not necessa-
rily mean that the patient is folate deficient. It only
means that the patient is consuming or absorbing less
folate, compared to normal subjects in the area. It is
recommended that laboratories not only report the nor-
mal range for SF and RF, but also to indicate the
expected range of SF and RF for truly folate deficient
individuals [16]. Most of the laboratories in US or
Canada, are no longer able to provide a reference range
for truly folate deficient individuals because they do not
have access to sufficient number of samples of blood
from truly folate deficient subjects. In the Herbert study
[18], the reference range for L. Casei microbiological
assay of SF was 15.9-36 nmol/L and folate deficient sub-
jects had SF of <6.8 nmol/L.
Relation of low folate assays and anemia due to folate
deficiency
Many physicians order serum folate, B12 and ferritin for
the investigation of anemia. If SF is low they assume
that the anemia is due to folate deficiency. This is not a
correct assumption. Anemia due to folate deficiency is
megaloblastic. No anemia should be attributed to folate
deficiency, unless there are megaloblastic changes in the
peripheral blood or in the bone marrow aspirate. Even
when there are megaloblastic changes in the bone mar-
row, the low SF or RF does not necessarily mean that
the patient is folate deficient. About 2-19% of patients
with pernicious anemia have low SF and, 23-62% have
low RF [19]. Serum folate falls below normal within a
short period of reduced dietary intake of folate. In the
past, low SF was found in 9-75% of probably normoblas-
tic hospitalized patients [19].
In the sequence of events leading to folate deficiency
anemia, the fall of SF is the earliest manifestation of
folate deficiency and anemia is a late manifestation of
folate deficiency. When a normal man was placed on a
folate deficient diet, his SF fell below normal by 3
weeks, RF fell below normal by 17 weeks, macocytic red
cells appeared in the blood smear by 18 weeks and ane-
mia and megaloblastic bone marrow developed at 19
weeks [20]. By the time that anemia had developed, his
SF was 1.0 nmol/L (normal range 15.9-36 nmol/L) and
his RF was 22 nmol/L.
As the result of fortification of grain products with
folic acid, dietary folate deficiency has become very rare.
Consequently, there is no longer any justification in
ordering folate assays to evaluate the folate status of the
patients. There are still some patients who may be folate
deficient (very small premature babies before they are
able to start taking grain products, pregnant women
who are not taking multivitamins and who also avoid
eating grain products, malnourished alcoholics or those
with celiac disease or tropical sprue who are avoiding
taking grain products). However, these patients could be
easily identified by their medical history and could be
placed on prophylactic folic acid therapy without testing
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their SB12 is normal.
In taking a patient’sd i e t a r yh i s t o r yt oa s s e s sd i e t a r y
intake of folates, physicians should note that, unlike the
past when fresh green leafy vegetables and fruits were
the major source of dietary folate, now, grain products
are the major source of dietary folate. In the last
NHANES, bread rolls and crackers were the single lar-
gest contributor of total folate to the American diet [7].
Conclusion
O u rd a t as h o wt h a t ,i nt h ec o u n t r i e sw h e r eg r a i np r o -
ducts are fortified with folic acid, ordering serum or red
cell folate for the investigation of anemia is a waste of
time and resources. Low SF or RF are very rare and
even in the few cases in which they are low, it is highly
unlikely that they could be low enough to cause anemia.
More importantly, the result of these tests is more likely
to mislead the physicians than to provide any useful
information.
Authors’ contributions
AMS conceived the research project, reviewed all the folate data and the
medical record of those with low red cell folate at SBGH and wrote this
manuscript. KvK reviewed all the folate data and medical record of those
with low serum or red cell folate at HSC. He has read and commented on
the manuscript. All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 January 2010
Accepted: 25 January 2010 Published: 25 January 2010
References
1. Food and Drug Administration: Food standards: amendment of standards
of identity for enriched grain products to require addition of folic acid.
Federal Register 61:8781-8797.
2. Health Canada: Food and Drug Regulations, Amendment. Schedule No.
1066. Ottawa 1998.
3. Lawrence JM, Petitti DB, Watkins M, Umekubo MA: Trends in serum folate
after food fortification. Lancet 1999, 354:915-6.
4. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH,
Selhub J: Folic acid fortification increases red blood cell folate
concentrations in the Framingham study. J Nutr 2001, 131:3277-80.
5. Ray JG, Vermeulen MJ, Boss SC, Cole DE: Declining rate of folate
insufficiency among adults following increased folic acid food
fortification in Canada. Can J Public Health 2002, 93:249-53.
6. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ: Biochemical
indicators of B vitamin status in the US population after folic acid
fortification: results from the National Health and Nutrition Examination
Survey 1999-2000. Am J Clin Nutr 2005, 82:442-50.
7. Dietrich M, Brown CJ, Block G: The effect of folate fortification of cereal-
grain products on blood folate status, dietary folate intake, and dietary
folate sources among adult non-supplement users in the United States.
J Am Coll Nutr 2005, 24:266-74.
8. Waters AH, Mollin DL: Studies on folic acid activity of human serum. J
Clin Pathol 1961, 14:335-344.
9. Hoffbrand AV, Newcombe FA, Mollin DL: Method of assay of red cell
folate activity and the value of the assay as a test for folate deficiency. J
Clin Pathol 1966, 19:17-28.
10. Quinlivan EP, Gregory JF: Effect of food fortification on folic acid intake in
the United States. Am J Clin Nutr 2003, 77:221-5.
11. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH,
Jacques PF: Folic acid intake from fortification in United States exceeds
predictions. J Nutr 2002, 132:2792-8.
12. Sheehy TW, Rubini M, Perez-Santiago E, Santini R Jr, Haddock J: The effect
of “minute” and “titrated” amount of folic acid on megaloblastic anemia
of tropical sprue. Blood 1961, 18:623-636.
13. Zalusky R, Herbert V: Megaloblastic anemia in scurvey with response to
50 microgram of folic acid daily. New Engl J Med 1961, 265:1033-1038.
14. Latif T, Hsi ED, Rybicki LA, Adelstein DJ: Is there a role for folate
determinations in current clinical practice in the USA?. Clin Lab Haematol
2004, 26:379-83.
15. Joelson DW, Fiebig EW, Wu AHB: Diminished need for folate
measurement among indigent populatios in the post folic acid
supplementation era. Arch Pathol Lab Med 2007, 131:477-480.
16. Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ:
Results of international round robin for serum and whole-blood folate.
Clin Chem 1996, 42:1689-94.
17. Bock JL, Endres DB, Elin RJ, Wang E, Rosenzweig B, Klee GG: Comparison of
fresh frozen serum to traditional proficiency testing material in a
College of American Pathologists survey for ferritin, folate, and vitamin
B12. Arch Pathol Lab Med 2005, 129:323-7.
18. Herbert V: Aseptic addition method for Lactobacillus casei assay of folate
activity in human serum. J Clin Pathol 1966, 19:12-6.
19. Chanarin I: The Megaloblastic Anemias. Blackwell Scientific Publication,
Oxford, 2 1979, 187-197.
20. Herbert V: Experimental nutritional folate deficiency in man. Trans Assoc
Am Physicians 1962, 75:307-20.
doi:10.1186/1756-0500-3-22
Cite this article as: Shojania and von Kuster: Ordering folate assays is no
longer justified for investigation of anemias, in folic acid fortified
countries. BMC Research Notes 2010 3:22.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Shojania and von Kuster BMC Research Notes 2010, 3:22
http://www.biomedcentral.com/1756-0500/3/22
Page 5 of 5